dx 9065a has been researched along with tetrodotoxin in 1 studies
| Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (tetrodotoxin) | Trials (tetrodotoxin) | Recent Studies (post-2010) (tetrodotoxin) |
|---|---|---|---|---|---|
| 92 | 7 | 8 | 12,992 | 11 | 1,477 |
| Protein | Taxonomy | dx 9065a (IC50) | tetrodotoxin (IC50) |
|---|---|---|---|
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 0.0186 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chino, D; Fujita, Y; Ishii, K; Nakayama, K | 1 |
1 other study(ies) available for dx 9065a and tetrodotoxin
| Article | Year |
|---|---|
Effects of DX-9065a, an inhibitor of factor Xa, on ellagic acid-induced plantar skin thrombosis assessed in tetrodotoxin- and N(omega)-nitro-L-arginine-treated rats.
Topics: Animals; Dose-Response Relationship, Drug; Ellagic Acid; Factor Xa Inhibitors; Hindlimb; Male; Naphthalenes; Nitroarginine; Propionates; Rats; Rats, Wistar; Skin; Skin Diseases; Tetrodotoxin; Thrombosis | 2003 |